Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (320)
  2. Meeting Abstract (278)
  3. Review (19)
  4. Editorial (9)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (649)
  2. Center for Hematologic Malignancies (649)
  3. Department of Medicine (649)
  4. Hematologic Malignancies, Division of (649)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (114)
  3. Jae Park (79)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (272)
  2. Journal of Clinical Oncology (41)
  3. Leukemia Research (27)
  4. Blood Advances (26)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (24)

More Publications

Publishers
  1. American Society of Hematology (298)
  2. Elsevier Inc. (43)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (649)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia
    Journal Article

    Iacobucci, I.; Li, Y.; Roberts, K. G.; Dobson, S. M.; Kim, J. C.; Payne-Turner, D.; Harvey, R. C.; Valentine, M.; McCastlain, K.; Easton, J.; more...
    Cancer Cell (2016)

    Fulltext@MSK | Save
  • Emerging therapeutic drugs for AML
    Journal Article

    Stein, E. M.; Tallman, M. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation outcomes in monosomal karyotype myeloid malignancies
    Journal Article

    Pasquini, M. C.; Zhang, M. J.; Medeiros, B. C.; Armand, P.; Hu, Z. H.; Nishihori, T.; Aljurf, M. D.; Akpek, G.; Cahn, J. Y.; Cairo, M. S.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Acute promyelocytic leukemia: Where did we start, where are we now, and the future
    Journal Article

    Coombs, C. C.; Tavakkoli, M.; Tallman, M. S.
    Blood Cancer Journal (2015)

    Fulltext@MSK | Save
  • Delays in intensification are common in adults with acute lymphoblastic leukemia (ALL), are associated with decreased survival in allogeneic hematopoietic cell transplant (HCT) patients
    Meeting Abstract

    Kumar, A.; Gimotty, P.; Gelfand, J.; Buck, G.; Rowe, J.; Goldstone, A.; Fielding, A.; Marks, D.; Litzow, M.; Paietta, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Very high dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia in the setting of intensified anthracycline induction and post stem-cell transplantation
    Meeting Abstract

    Itchaki, G.; Wolach, O.; Bar-Natan, M.; Yeshurun, M.; Ram, R.; Herscovici, C.; Douer, D.; Tallman, M.; Shpilberg, O.; Raanani, P.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Clinical description of acute promyelocytic leukemia (APL) patients receiving all-trans retinoic acid (ATRA) who develop pseudotumor cerebri: Incidence, diagnosis, outcomes, and recommendations for management
    Meeting Abstract

    Coombs, C. C.; DeAngelis, L. M.; Feusner, J. H.; Tallman, M. S.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Astarabine, a pro-drug of cytarabine, is safe for patients with advanced acute leukemia. A phase I/IIa single center study in relapsed/refractory or medically unfit patients
    Meeting Abstract

    Zuckerman, T.; Ben Yakar, R.; Gengrinovitch, S.; Hoffman, R.; Henig, I.; Lavi, N.; Akria, L.; Ofran, Y.; Nudelman, O.; Haddad, N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in adults with relapsed or refractory leukemia: Safety, clinical activity, exposure and target inhibition
    Meeting Abstract

    Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Tibes, R.; Berdeja, J. G.; Jongen-Lavrencic, M.; Altman, J. K.; Dohner, H.; Thomson, B.; Blakemore, S. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The aberrantly expressed long noncoding RNA, TRERNA1, predicts for aggressive disease in chronic lymphocytic leukemia
    Meeting Abstract

    Miller, C. R.; Ruppert, A. S.; Coombes, K.; Lehman, A. M.; Blachly, J. S.; Lucas, D. M.; Grever, M. R.; Tallman, M. S.; Flinn, I. W.; Rassenti, L. Z.; more...
    Blood (2015)

    Fulltext@MSK | Save